Skip to main content
. 2019 Jul 12;27(7):849–858. doi: 10.3727/096504018X15447833065047

Figure 1.

Figure 1

Overview of the natural compound triptolide (TPL) on aberrant molecular signaling pathways for non-small cell lung cancer (NSCLC) research and therapy. TPL exerts its anticancer effects by inhibiting proliferation, suppressing survival, and inducing apoptosis of NSCLC cells via modulating several key signaling pathways, including MAPK, NF-κB, and FAK.